Goldenwell Biotech: From $0.2 Low to $10 High—What Investors Must Watch Now
Goldenwell Biotech’s volatile journey: from a 52‑week low of $0.2 to $10 highs, a $297 M market cap and a -3330 P/E, all driven by heavy R&D and investor optimism. Discover how the biotech firm’s future breakthroughs could reshape its profitability …
2 minutes to read